MLTX Annual Current Liabilities
$9.97 M
+$2.30 M+30.01%
31 December 2023
Summary:
As of January 23, 2025, MLTX annual total current liabilities is $9.97 million, with the most recent change of +$2.30 million (+30.01%) on December 31, 2023. During the last 3 years, it has fallen by -$11.12 million (-52.74%). MLTX annual current liabilities is now -52.74% below its all-time high of $21.09 million, reached on December 31, 2021.MLTX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MLTX Quarterly Current Liabilities
$20.08 M
+$7.80 M+63.50%
30 September 2024
Summary:
As of January 23, 2025, MLTX quarterly total current liabilities is $20.08 million, with the most recent change of +$7.80 million (+63.50%) on September 30, 2024. Over the past year, it has increased by +$7.80 million (+63.50%). MLTX quarterly current liabilities is now -4.77% below its all-time high of $21.09 million, reached on December 31, 2021.MLTX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MLTX Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +30.0% | +63.5% |
| 3 y3 years | -52.7% | -4.8% |
| 5 y5 years | -52.7% | -4.8% |
MLTX Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -52.7% | +30.0% | -4.8% | +420.6% |
| 5 y | 5-year | -52.7% | +30.0% | -4.8% | +420.6% |
| alltime | all time | -52.7% | +30.0% | -4.8% | +420.6% |
MoonLake Immunotherapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $20.08 M(+63.5%) |
| June 2024 | - | $12.28 M(+37.8%) |
| Mar 2024 | - | $8.91 M(-10.6%) |
| Dec 2023 | $9.97 M | $9.97 M(-3.3%) |
| Sept 2023 | - | $10.31 M(+44.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $7.13 M(-2.0%) |
| Mar 2023 | - | $7.28 M(-5.0%) |
| Dec 2022 | $7.67 M(-63.6%) | $7.67 M(+27.4%) |
| Sept 2022 | - | $6.02 M(+56.0%) |
| June 2022 | - | $3.86 M(-81.7%) |
| Dec 2021 | $21.09 M | $21.09 M |
FAQ
- What is MoonLake Immunotherapeutics annual total current liabilities?
- What is the all time high annual current liabilities for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual current liabilities year-on-year change?
- What is MoonLake Immunotherapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly current liabilities year-on-year change?
What is MoonLake Immunotherapeutics annual total current liabilities?
The current annual current liabilities of MLTX is $9.97 M
What is the all time high annual current liabilities for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual total current liabilities is $21.09 M
What is MoonLake Immunotherapeutics annual current liabilities year-on-year change?
Over the past year, MLTX annual total current liabilities has changed by +$2.30 M (+30.01%)
What is MoonLake Immunotherapeutics quarterly total current liabilities?
The current quarterly current liabilities of MLTX is $20.08 M
What is the all time high quarterly current liabilities for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly total current liabilities is $21.09 M
What is MoonLake Immunotherapeutics quarterly current liabilities year-on-year change?
Over the past year, MLTX quarterly total current liabilities has changed by +$7.80 M (+63.50%)